Breathe Well Live Well
|
Team develops new approach to identify genes poised to respond in asthma …
Medical Xpress In a study published yesterday in the scientific journal Nature Immunology, a group at the La Jolla Institute (LJI) led by Pandurangan Vijayanand, Ph.D. identify new genes that likely contribute to asthma, a disease that currently affects over 200 … |
View full post on asthma – Google News
|
LJI develops new approach to identify genes poised to respond in asthma patients
Science Codex SAN DIEGO – July 8, 2014 In a study published yesterday in the scientific journal Nature Immunology, a group at the La Jolla Institute (LJI) led by Pandurangan Vijayanand, Ph.D. identify new genes that likely contribute to asthma, a disease that … |
View full post on asthma – Google News
|
MediciNova Asthma Compound Poised for Late-Stage Trials
San Diego Business Journal By Julie Gallant Tuesday, May 29, 2012 Local biopharmaceutical company MediciNova Inc. received enough positive news from a phase 2b clinical trial evaluating its MN-221 asthma compound to pursue planning for phase 3 trials. |
View full post on asthma – Google News
|
New asthma research poised to save hundreds of lives a year
Scottish Daily Record SCIENTISTS hope to prevent 1100 deaths a year after discovering a new cause of severe asthma. The breakthrough centres on the five to 10 per cent of patients who do not respond to treatment with standard inhalers. Professor Mark Lindsay's team … |
View full post on asthma – Google News
|
Theravance Poised to Jump
Minyanville.com The drug, Relovair, is being tested as a once-daily treatment for chronic obstructive pulmonary disease and asthma. Glaxo sees it as a successor to Advair, … |
View full post on asthma – Google News